Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Dana-Farber) July 23, 2014 - In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.
read press release »
(Wall Street Journal) July 23, 2014 - A new study finds treating bladder cancer with a surgical robot made by Intuitive Surgical is no better at reducing procedural complications than performing the procedure with traditional surgery, a result that surprised researchers, who had expected the robotic technology to be superior to human hands alone.
read article (paid subscription required) »
(Reuters) July 24, 2014 - U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for patients with low white blood cell counts.
read article »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
Sunesis Pharmaceuticals, Inc. has 2 jobs posted.
Novocure has posted 4 jobs.